HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survival rate in children with fulminant hepatitis improved by a combination of twice daily plasmapheresis and intensive conservative therapy.

Abstract
Six of seven children with fulminant hepatitis (FH) were treated with a combination of twice daily plasmapheresis and intensive conservative therapy including special amino acid solution, glucagon-insulin therapy, dexamethasone, and so on. The remaining child was treated with intensive conservative therapy only because his condition was not so severe, in spite of being diagnosed as having fulminant hepatitis. Although five patients with biopsy-documented bridging hepatic necrosis or confluent hepatic necrosis in the acute phase made recoveries, the remaining two with massive hepatic necrosis died (the overall survival rate was 71%). The prognostic factors were considered to be the degree and pattern of liver cell necrosis, the degree of coma, and the etiology. The combination of twice daily plasmapheresis and intensive conservative therapy was effective for these pediatric patients with fulminant hepatitis, except those with massive hepatic necrosis.
AuthorsK Shin, Y Nagai, C Hirano, N Kataoka, I Ono, E Yamamura, C Moriyama, Y Horigome, T Ehara, T Kamoda
JournalJournal of pediatric gastroenterology and nutrition (J Pediatr Gastroenterol Nutr) Vol. 9 Issue 2 Pg. 163-6 (Aug 1989) ISSN: 0277-2116 [Print] United States
PMID2509666 (Publication Type: Journal Article)
Topics
  • Acute Disease
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Evaluation Studies as Topic
  • Female
  • Hepatic Encephalopathy (mortality, therapy)
  • Hepatitis (mortality, therapy)
  • Humans
  • Infant
  • Male
  • Parenteral Nutrition
  • Plasmapheresis (methods)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: